专访新晋中国科学院院士胡海岚：拥抱新挑战，是个人以及职业成长的关键

Core Insights - Hu Hailan, a professor at Zhejiang University, was elected as an academician of the Chinese Academy of Sciences in the life sciences and medicine division, recognized for her work in understanding emotions, social behavior, and mental disorders from a molecular genetics perspective [2][4] - Hu Hailan was also featured in Cell Press's "50 Scientists that Inspire" series, celebrating her contributions to science and encouraging aspiring scientists to embrace new challenges for personal and professional growth [2][4] Group 1: Achievements and Recognition - Hu Hailan has received numerous awards, including the 12th IBRO-Kemali International Prize and the World Outstanding Woman Scientist Award, highlighting her significant contributions to neuroscience [4] - The "50 Scientists that Inspire" series by Cell Press aims to provide insights into the lives and hopes of influential scientists, with 14 of the featured scientists being of Chinese descent [2][4] Group 2: Research Focus - Hu Hailan's laboratory primarily investigates the molecular and neural circuit mechanisms underlying social behavior and mental disorders, emphasizing the importance of interdisciplinary approaches in scientific research [4][10] - Current research interests include the mechanisms of rapid-acting psychiatric drugs, which offer unique opportunities to study the fundamental brain mechanisms of mental disorders [10] Group 3: Personal Insights and Advice - Hu Hailan encourages aspiring scientists to explore various disciplines early in their careers, as diverse experiences can lead to creativity and innovation in scientific exploration [11][12] - She emphasizes the importance of balancing research work with administrative responsibilities, advocating for open communication and collaboration within teams [9] Group 4: Future Perspectives - Looking ahead, Hu Hailan envisions a transformative era in neuroscience and medicine, similar to advancements seen in cancer treatment, with the potential for effective treatments for debilitating brain diseases [13]